FRACTION-RCC: nivolumab plus ipilimumab for advanced renal cell carcinoma after progression on immuno-oncology therapy.

Toni K ChoueiriHarriet KlugerSaby GeorgeScott S TykodiTimothy M KuzelRuth PeretsSuresh NairGiuseppe ProcopioMichael A CarducciVincent CastonguayEdmund FolefacChung-Han LeeSebastien J HotteWilson H MillerShruti Shally SaggiChung-Wei LeeHeshani DesilvaPrabhu BhagavatheeswaranRobert J MotzerBernard Escudier

Published in: Journal for immunotherapy of cancer (2022)

NCT02996110.

Keyphrases

renal cell carcinoma
palliative care
stem cells
bone marrow
mesenchymal stem cells